NRC Health (NASDAQ: NRC) insider transactions
In the twelve months to 10 November 2026, executives and directors of NRC Health reported 0 open-market sales and 1 open-market purchase of 8,000 shares ($98,160), by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 23 June 2026 | Wheeler Penny Ann | Director | Grant or award | +7,697 | — | 7,697 | Form 4 |
| 23 June 2026 | Nunnelly John N | Director | Grant or award | +7,697 | — | 40,363 | Form 4 |
| 23 June 2026 | Lockhart Stephen H | Director | Grant or award | +7,697 | — | 7,697 | Form 4 |
| 23 June 2026 | Bhandari Parul | Director | Grant or award | +7,697 | — | 7,697 | Form 4 |
| 23 June 2026 | Berwick Donald M | Director | Grant or award | +7,697 | — | 7,697 | Form 4 |
| 12 March 2026 | Rau Jason Russell | Executive Vice President | Grant or award | +60,000 | — | 60,000 | Form 4 |
| 17 February 2026 | Harrison Shane R | EVP & Chief Financial Officer | Open-market purchase | +8,000 | $12.27 | 8,000 | Form 4 |
| 5 January 2026 | Burik David | EVP, Strategic Insights | Grant or award | +100,000 | — | 100,000 | Form 4 |
| 5 January 2026 | Hays Michael D. | Chairman | Option exercise | +9,145 | $15.23 | 20,154 | Form 4 |
| 29 December 2025 | Harrison Shane R | EVP & Chief Financial Officer | Shares withheld for tax | −21,271 | $18.66 | 150,729 | Form 4 |
| 15 December 2025 | Hrdy Helen | EVP & Chief Operating Officer | Option exercise | +12,346 | $15.23 | 151,762 | Form 4 |
| 15 December 2025 | Hrdy Helen | EVP & Chief Operating Officer | Shares withheld for tax | −11,244 | $17.64 | 140,518 | Form 4 |
| 29 September 2025 | Harrison Shane R | EVP & Chief Financial Officer | Grant or award | +172,000 | — | 172,000 | Form 4 |
| 31 July 2025 | Freeman Jordan Nicole | Chief Accounting Officer | Open-market purchase | +771 | $12.97 | 771 | Form 4 |
| 1 June 2025 | Green Trent S | Chief Executive Officer | Grant or award | +500,000 | — | 500,000 | Form 4 |
| 12 May 2025 | Beans Patrick E | — | Open-market purchase | +2,500 | $13.59 | 35,003 | Form 4 |
| 7 April 2025 | Hrdy Helen | Chief Operating Officer | Grant or award | +100,000 | — | 139,416 | Form 4 |
| 7 April 2025 | Monnich Andrew | Chief Corp. Development Off. | Grant or award | +100,000 | — | 100,000 | Form 4 |
| 2 January 2025 | Hays Michael D. | CEO & President | Option exercise | +10,014 | $13.17 | 11,009 | Form 4 |
| 31 December 2024 | Amandla MK Trust | — | Gift | −4,755,317 | — | 0 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the NRC Health page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.